BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 24259595)

  • 1. Proactive pharmaceutical care interventions improve patients' adherence to lipid-lowering medication.
    Stuurman-Bieze AG; Hiddink EG; van Boven JF; Vegter S
    Ann Pharmacother; 2013 Nov; 47(11):1448-56. PubMed ID: 24259595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proactive pharmaceutical care interventions decrease patients' nonadherence to osteoporosis medication.
    Stuurman-Bieze AG; Hiddink EG; van Boven JF; Vegter S
    Osteoporos Int; 2014 Jun; 25(6):1807-12. PubMed ID: 24570297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving adherence to lipid-lowering therapy in a community pharmacy intervention program: a cost-effectiveness analysis.
    Vegter S; Oosterhof P; van Boven JF; Stuurman-Bieze AG; Hiddink EG; Postma MJ
    J Manag Care Spec Pharm; 2014 Jul; 20(7):722-32. PubMed ID: 24967525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication monitoring and optimization: a targeted pharmacist program for effective and cost-effective improvement of chronic therapy adherence.
    van Boven JF; Stuurman-Bieze AG; Hiddink EG; Postma MJ; Vegter S
    J Manag Care Spec Pharm; 2014 Aug; 20(8):786-92. PubMed ID: 25062071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of medication review and cognitive behaviour treatment by community pharmacists of patients discharged from the hospital on drug related problems and compliance: design of a randomized controlled trial.
    Ahmad A; Hugtenburg J; Welschen LM; Dekker JM; Nijpels G
    BMC Public Health; 2010 Mar; 10():133. PubMed ID: 20230611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A community pharmacist delivered adherence support service for dyslipidaemia.
    Aslani P; Rose G; Chen TF; Whitehead PA; Krass I
    Eur J Public Health; 2011 Oct; 21(5):567-72. PubMed ID: 20817685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness of pharmaceutical care for patients with COPD: translated review of the recently published PHARMACOP trial].
    Tommelein E; Mehuys E; Van Hees T; Adriaens E; Van Bortel L; Christiaens T; Van Tongelen I; Remon JP; Boussery K; Brusselle G
    J Pharm Belg; 2014 Sep; (3):4-14. PubMed ID: 25226757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a community pharmacists' hypertension-care service on medication adherence. The AFenPA study.
    Fikri-Benbrahim N; Faus MJ; Martínez-Martínez F; Sabater-Hernández D
    Res Social Adm Pharm; 2013; 9(6):797-805. PubMed ID: 23391845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients' general satisfaction with telephone counseling by pharmacists and effects on satisfaction with information and beliefs about medicines: Results from a cluster randomized trial.
    Kooy MJ; Van Geffen EC; Heerdink ER; Van Dijk L; Bouvy ML
    Patient Educ Couns; 2015 Jun; 98(6):797-804. PubMed ID: 25791373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Medicines Advice Service Evaluation (MASE): a randomised controlled trial of a pharmacist-led telephone based intervention designed to improve medication adherence.
    Lyons I; Barber N; Raynor DK; Wei L
    BMJ Qual Saf; 2016 Oct; 25(10):759-69. PubMed ID: 26755665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of a pharmaceutical care program in a community pharmacy on patients with dyslipidemia.
    Paulós CP; Nygren CE; Celedón C; Cárcamo CA
    Ann Pharmacother; 2005 May; 39(5):939-43. PubMed ID: 15827075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacist intervention program for control of hypertension.
    Chabot I; Moisan J; Grégoire JP; Milot A
    Ann Pharmacother; 2003 Sep; 37(9):1186-93. PubMed ID: 12921497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a pharmacist intervention on patients initiating pharmacological treatment for depression: a randomized controlled superiority trial.
    Rubio-Valera M; March Pujol M; Fernández A; Peñarrubia-María MT; Travé P; López Del Hoyo Y; Serrano-Blanco A
    Eur Neuropsychopharmacol; 2013 Sep; 23(9):1057-66. PubMed ID: 23219937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a pharmacy-based health literacy intervention and patient characteristics on medication refill adherence in an urban health system.
    Gazmararian J; Jacobson KL; Pan Y; Schmotzer B; Kripalani S
    Ann Pharmacother; 2010 Jan; 44(1):80-7. PubMed ID: 20028960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safe and effective use of medicines for patients with type 2 diabetes - A randomized controlled trial of two interventions delivered by local pharmacies.
    Kjeldsen LJ; Bjerrum L; Dam P; Larsen BO; Rossing C; Søndergaard B; Herborg H
    Res Social Adm Pharm; 2015; 11(1):47-62. PubMed ID: 24798710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intervention through a pharmaceutical care program on patient adherence with prescribed once-daily atorvastatin.
    Vrijens B; Belmans A; Matthys K; de Klerk E; Lesaffre E
    Pharmacoepidemiol Drug Saf; 2006 Feb; 15(2):115-21. PubMed ID: 16342302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-centered adherence intervention after acute coronary syndrome hospitalization.
    Lambert-Kerzner A; Del Giacco EJ; Fahdi IE; Bryson CL; Melnyk SD; Bosworth HB; Davis R; Mun H; Weaver J; Barnett C; Radcliff T; Hubbard A; Bosket KD; Carey E; Virchow A; Mihalko-Corbitt R; Kaufman A; Marchant-Miros K; Ho PM;
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):571-6. PubMed ID: 22811499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients' satisfaction with information and experiences with counseling on cardiovascular medication received at the pharmacy.
    van Geffen EC; Philbert D; van Boheemen C; van Dijk L; Bos MB; Bouvy ML
    Patient Educ Couns; 2011 Jun; 83(3):303-9. PubMed ID: 21550196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical care for migraine and headache patients: a community-based, randomized intervention.
    Hoffmann W; Herzog B; Mühlig S; Kayser H; Fabian R; Thomsen M; Cramer M; Fiss T; Gresselmeyer D; Janhsen K
    Ann Pharmacother; 2008 Dec; 42(12):1804-13. PubMed ID: 19001531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subjects at risk of discontinuation of lipid-lowering agents: a 6-month cohort study among 12,875 patients in a chinese population.
    Wong MC; Jiang JY; Yan BP; Griffiths SM
    Clin Ther; 2011 May; 33(5):617-28. PubMed ID: 21665046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.